{
    "uniprot_canonical_ac": "A4UUI3-1", 
    "publication_count": 6, 
    "reported_interactions": 0, 
    "record_type": "protein", 
    "predicted_glycosites": 0, 
    "protein_names_refseq": "guanylate-binding protein 4 homolog; guanylate nucleotide binding protein 4; macrophage activation 2; macrophage activation 2 isoform 1", 
    "refseq_ac": "NP_001242934.1", 
    "reported_n_glycosites": 0, 
    "refseq_name": "macrophage activation 2 isoform 1", 
    "record_id": "A4UUI3-1", 
    "protein_names_uniprotkb": "Guanylate binding protein 4.1; Guanylate-binding protein 4; Truncated guanylate binding protein 4", 
    "pathway": " (mmu:17472)", 
    "function": "GBP4 is a negative regulator of virus-triggered type I interferon (IFN-I) production, interacting as a novel protein targeting interferon regulatory factor (IRF)-7 and inhibiting its function., [RefSeq]; Two splice variants of mGBP4 could be detected. One variant led to a premature stop codon after 312 bp. The second variant resulted in a transcript with a disrupted G2 domain., [RefSeq]", 
    "protein_name": "Guanylate binding protein 4.1; Guanylate-binding protein 4; Truncated guanylate binding protein 4", 
    "reported_mutagensis": 0, 
    "reported_phosphosites": 0, 
    "reported_o_glycosites_with_glycan": 0, 
    "tax_id": 10090, 
    "organism": "Mus musculus", 
    "disease": "", 
    "reported_glycation": 0, 
    "reported_snv": 0, 
    "mass": 72042.0, 
    "gene_names_uniprotkb": "Gbp4", 
    "reported_n_glycosites_with_glycan": 0, 
    "reported_o_glycosites": 0, 
    "gene_names_refseq": "AW228052; Mag-; Mag-2; Mp; Mpa; Mpa-2; Mpa2; Gbp4", 
    "gene_name": "Gbp4"
}